MIT's EV Design Database, HIV Drug Named Breakthrough of 2024, and DeepSeek's New Open Source AI Model

Discover Daily by Perplexity

We're experimenting and would love to hear from you!

In this episode of Discover Daily, we explore groundbreaking technological and scientific developments shaping our future. MIT's revolutionary DrivAerNet++ database takes center stage, featuring over 8,000 AI-generated electric vehicle designs with comprehensive aerodynamic data, promising to transform automotive development processes and accelerate EV innovation.
The show delves into a major medical breakthrough as lenacapavir, Science magazine's 2024 Breakthrough of the Year, emerges as a game-changing HIV prevention drug. This remarkable innovation from Gilead Sciences offers six months of protection with a single injection, demonstrating 96-100% efficacy in clinical trials and holding promise for global HIV prevention efforts.
The episode's main focus spotlights DeepSeek-V3, a cutting-edge open-source AI model boasting 671 billion parameters. Using innovative Mixture-of-Experts architecture, this powerful language model activates only 37 billion parameters per token, achieving impressive efficiency while maintaining high performance across various text-based tasks. The discussion explores its capabilities, limitations, and potential impact on the AI landscape.
From Perplexity's Discover Feed:
https://www.perplexity.ai/page/mit-s-ev-design-database-HW3LeM4gQNO2pa1oYp6AMw
https://www.perplexity.ai/page/hiv-drug-named-breakthrough-of-kzPk2YAoQPKS.CdzOsNdXA
https://www.perplexity.ai/page/deepseek-s-new-open-source-ai-YwAwjp_IQKiAJ2l1qFhN9g

Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you’re interested in.
Take the world's knowledge with you anywhere. Available on iOS and Android
Join our growing Discord community for the latest updates and exclusive content.
Follow us on:

• Instagram
• Threads
• X (Twitter)
• YouTube
• Linkedin